Showing results (431-440 of 909) with videos related to
Sort By:
Pageof 91
Antimicrobial Agents and Chemotherapy|December 25, 2002
Enzymatic assay for measurement of intracellular DXG triphosphate concentrations in peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected patientsStephen Kewn, Laurene H Wang, Patrick G Hoggard, et al.AIDS (London, England)|July 24, 1998
The pharmacokinetics of combination therapy with nelfinavir plus nevirapineC Merry, M G Barry, F Mulcahy, et al.Sexually Transmitted Infections|February 15, 2013
Non-disclosure of HIV status in UK sexual health clinics--a pilot study to identify non-disclosure within a national unlinked anonymous seroprevalence surveyAnn Kathleen Sullivan, Emma J Savage, Catherine M Lowndes, et al.The Journal of Bone and Joint Surgery. American Volume|May 10, 2024
Evaluating the Ability of Brachial Plexus-Injured Patients to Control an Externally Powered (Myoelectric) Hand ProsthesisEllen Y Lee, Andrew W Nelson, Brandon P Sampson, et al.Histopathology|June 14, 2012
Increased expression of the 5-lipoxygenase pathway and its cellular localization in Barrett's adenocarcinomaPhilip C Boger, James D Shutt, James R Neale, et al.Journal of Neurosurgery|September 5, 2025
Activity performance in patients with traumatic brachial plexus injuries after elective amputation and myoelectric hand prosthetic fittingTiam M Saffari, Andrew W Nelson, Brandon P Sampson, et al.Pediatric Radiology|June 12, 2021
Pediatric contrast-enhanced ultrasound: shedding light on the pursuit of approval in the United StatesKassa Darge, Susan J Back, Dorothy I Bulas, et al.The Journal of Antimicrobial Chemotherapy|July 16, 2004
Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semenAdil Isaac, Stephen Taylor, Patricia Cane, et al.Pediatric Radiology|June 27, 2024
Radiographic calibration for pubic diastasis assessment in bladder exstrophy-epispadias complex: a phantom studyS J Back, D A Weiss, B Marshall, et al.Antimicrobial Agents and Chemotherapy|November 17, 2010
Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovirDarren M Moss, Wai San Kwan, Neill J Liptrott, et al.Pageof 91